Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Use of Radiation in Extramedullary Leukemia/Chloroma: Guidelines From the International Lymphoma Radiation Oncology Group

Publikation: Bidrag til tidsskriftReviewForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{523390341a1344efb4fe9e0a6aa09cce,
title = "Use of Radiation in Extramedullary Leukemia/Chloroma: Guidelines From the International Lymphoma Radiation Oncology Group",
abstract = "Survival times for patients with leukemia generally have improved in recent decades, and this improvement has been attributed to an enhanced understanding of the genetics driving the cause of the disease and improved combinations of chemotherapy and targeted therapy. Durable control of systemic disease in blood and bone marrow has significantly improved survival, but extramedullary relapse can pose therapeutic challenges for which radiation therapy can have an important role. This report discusses the current role of radiation therapy for patients with leukemia, specifically the extramedullary manifestations of leukemia.",
author = "Bakst, {Richard L} and Dabaja, {Bouthaina Shbib} and Specht, {Lena K} and Joachim Yahalom",
note = "Copyright {\circledC} 2018. Published by Elsevier Inc.",
year = "2018",
month = "10",
day = "1",
doi = "10.1016/j.ijrobp.2018.05.045",
language = "English",
volume = "102",
pages = "314--319",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc",
number = "2",

}

RIS

TY - JOUR

T1 - Use of Radiation in Extramedullary Leukemia/Chloroma

T2 - Guidelines From the International Lymphoma Radiation Oncology Group

AU - Bakst, Richard L

AU - Dabaja, Bouthaina Shbib

AU - Specht, Lena K

AU - Yahalom, Joachim

N1 - Copyright © 2018. Published by Elsevier Inc.

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Survival times for patients with leukemia generally have improved in recent decades, and this improvement has been attributed to an enhanced understanding of the genetics driving the cause of the disease and improved combinations of chemotherapy and targeted therapy. Durable control of systemic disease in blood and bone marrow has significantly improved survival, but extramedullary relapse can pose therapeutic challenges for which radiation therapy can have an important role. This report discusses the current role of radiation therapy for patients with leukemia, specifically the extramedullary manifestations of leukemia.

AB - Survival times for patients with leukemia generally have improved in recent decades, and this improvement has been attributed to an enhanced understanding of the genetics driving the cause of the disease and improved combinations of chemotherapy and targeted therapy. Durable control of systemic disease in blood and bone marrow has significantly improved survival, but extramedullary relapse can pose therapeutic challenges for which radiation therapy can have an important role. This report discusses the current role of radiation therapy for patients with leukemia, specifically the extramedullary manifestations of leukemia.

U2 - 10.1016/j.ijrobp.2018.05.045

DO - 10.1016/j.ijrobp.2018.05.045

M3 - Review

VL - 102

SP - 314

EP - 319

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 2

ER -

ID: 55856678